Oxford Biomedica Solutions Publishes Peer-Reviewed Journal Article On Novel Dual-Plasmid System, Resulting In Significantly Increased AAV Vector Productivity And Percentage Of Full Capsids Packaged
June 08, 2023 10:00 ET
|
Oxford Biomedica Solutions LLC
BEDFORD, Mass., June 08, 2023 (GLOBE NEWSWIRE) -- Oxford Biomedica Solutions LLC, offers The Full Solution™ suite of services, which includes end-to-end development and manufacturing capabilities...
Oxford Biomedica Solutions to Present Company Capabilities and its Platform at American Society of Gene and Cell Therapy in Los Angeles
May 09, 2023 10:00 ET
|
Oxford Biomedica Solutions LLC
BEDFORD, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Oxford Biomedica Solutions LLC, offers The Full Solution™ services, which includes end-to-end development and manufacturing capabilities. The...
Oxford Biomedica Solutions forms new partnerships with three biotechnology companies
December 14, 2022 08:53 ET
|
Oxford Biomedica Solutions LLC
BEDFORD, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Oxford Biomedica Solutions LLC, an AAV manufacturing and innovation company, announced today that it has signed agreements with three additional...
Oxford Biomedica Solutions to Present Company Capabilities & Its Platform at Cell & Gene Meeting on the Mesa and European Society of Gene & Cell Therapy
October 05, 2022 08:46 ET
|
Oxford Biomedica Solutions LLC
BEDFORD, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Oxford Biomedica Solutions LLC, an Oxford Biomedica company that offers an end-to-end, full solution platform approach to the development and...
Oxford Biomedica Solutions signs agreement with new partner to deliver The Full Solution for their AAV programs
September 14, 2022 07:00 ET
|
Oxford Biomedica Solutions LLC
Oxford Biomedica Solutions signs agreement with new partner to deliver The Full Solution for their AAV programs Bedford, Massachusetts – September 14, 2022: Oxford Biomedica Solutions LLC, an Oxford...